TGTX opens lower but pares losses on Novartis data, Wainwright note
TG Therapeutics (TGTX) opened lower Tuesday, then pared losses as investors digested Novartis multiple sclerosis pill data and an H.C. Wainwright note from Emily Bodnar saying the results do not threaten Briumvi.
Shares of TG Therapeutics (TGTX) opened lower on Tuesday but trimmed losses as investors weighed Novartis’s new multiple sclerosis pill data and a note from H.C. Wainwright saying the results do not threaten TGTX’s main drug, Briumvi. H.C. Wainwright analyst Emily Bodnar said Novartis’s remibrutinib…